Ancestry as a potential modifier of gene expression in breast tumors from Colombian women

作者: Silvia J. Serrano-Gómez , María Carolina Sanabria-Salas , Jone Garay , Melody C. Baddoo , Gustavo Hernández-Suarez

DOI: 10.1371/JOURNAL.PONE.0183179

关键词:

摘要: Author(s): Serrano-Gomez, Silvia J; Sanabria-Salas, Maria Carolina; Garay, Jone; Baddoo, Melody C; Hernandez-Suarez, Gustavo; Mejia, Juan Carlos; Garcia, Oscar; Miele, Lucio; Fejerman, Laura; Zabaleta, Jovanny | Abstract: BackgroundHispanic/Latino populations are a genetically admixed and heterogeneous group, with variable fractions of European, Indigenous American African ancestries. The molecular profile breast cancer has been widely described in non-Hispanic Whites but equivalent knowledge is lacking Hispanic/Latinas. We have previously reported that the most prevalent intrinsic subtype Colombian women was Luminal B as defined by St. Gallen 2013 criteria. In this study we explored ancestry-associated differences profiles tumors among these highly women.MethodsWe performed whole-transcriptome RNA-seq analysis 42 (21 A 21 B) from women. Genetic ancestry estimated panel 80 ancestry-informative markers (AIM). categorized patients according to proportion European differential expression comparing against assigned groups.ResultsWe found 5 genes potentially modulated genetic ancestry: ERBB2 (log2FC = 2.367, padjl0.01), GRB7 2.327, GSDMB 1.723, padjl0.01, MIEN1 2.195, padjl0.01 ONECUT2 2.204, padjl0.01). replication set statistical significant association between (p 0.02, 3.11). This not biased distribution HER2+ groups analyzed.ConclusionsOur results suggest Hispanic/Latina might modify gene tumors. Further analyses needed confirm findings explore their prognostic value.

参考文章(65)
Monica D’Arcy, Jodie Fleming, Whitney R. Robinson, Erin L. Kirk, Charles M. Perou, Melissa A. Troester, Race-associated biological differences among Luminal A breast tumors Breast Cancer Research and Treatment. ,vol. 152, pp. 437- 448 ,(2015) , 10.1007/S10549-015-3474-4
Zhiyuan Hu, Cheng Fan, Daniel S Oh, JS Marron, Xiaping He, Bahjat F Qaqish, Chad Livasy, Lisa A Carey, Evangeline Reynolds, Lynn Dressler, Andrew Nobel, Joel Parker, Matthew G Ewend, Lynda R Sawyer, Junyuan Wu, Yudong Liu, Rita Nanda, Maria Tretiakova, Alejandra Ruiz Orrico, Donna Dreher, Juan P Palazzo, Laurent Perreard, Edward Nelson, Mary Mone, Heidi Hansen, Michael Mullins, John F Quackenbush, Matthew J Ellis, Olufunmilayo I Olopade, Philip S Bernard, Charles M Perou, The molecular portraits of breast tumors are conserved across microarray platforms BMC Genomics. ,vol. 7, pp. 96- 96 ,(2006) , 10.1186/1471-2164-7-96
Osvaldo Artigalás, Tazio Vanni, Mara Helena Hutz, Patricia Ashton-Prolla, Ida Vanessa Schwartz, None, Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis BMC Medicine. ,vol. 13, pp. 139- 139 ,(2015) , 10.1186/S12916-015-0373-9
Ozlem Yersal, Biological subtypes of breast cancer: Prognostic and therapeutic implications. World journal of clinical oncology. ,vol. 5, pp. 412- 424 ,(2014) , 10.5306/WJCO.V5.I3.412
Paul A. Stewart, Jennifer Luks, Mark D. Roycik, Qing-Xiang Amy Sang, Jinfeng Zhang, Differentially expressed transcripts and dysregulated signaling pathways and networks in African American breast cancer. PLOS ONE. ,vol. 8, ,(2013) , 10.1371/JOURNAL.PONE.0082460
François Bertucci, Nathalie Borie, Christophe Ginestier, Agnès Groulet, Emmanuelle Charafe-Jauffret, José Adélaïde, Jeannine Geneix, Loïc Bachelart, Pascal Finetti, Alane Koki, Fabienne Hermitte, Jacques Hassoun, Stéphane Debono, Patrice Viens, Vincent Fert, Jocelyne Jacquemier, Daniel Birnbaum, Identification and validation of an ERBB2 gene expression signature in breast cancers Oncogene. ,vol. 23, pp. 2564- 2575 ,(2004) , 10.1038/SJ.ONC.1207361
Xiaoyan Huang, Matteo Dugo, Maurizio Callari, Marco Sandri, Loris De Cecco, Barbara Valeri, Maria Luisa Carcangiu, Jingyan Xue, Rui Bi, Silvia Veneroni, Maria Grazia Daidone, Sylvie Ménard, Elda Tagliabue, Zhimin Shao, Jiong Wu, Rosaria Orlandi, Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtype. Cancer Medicine. ,vol. 4, pp. 1016- 1030 ,(2015) , 10.1002/CAM4.442
E. H. Lips, L. Mulder, J. J. de Ronde, I. A. M. Mandjes, B. B. Koolen, L. F. A. Wessels, S. Rodenhuis, J. Wesseling, Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response. Breast Cancer Research and Treatment. ,vol. 140, pp. 63- 71 ,(2013) , 10.1007/S10549-013-2620-0
Yanyuan Wu, Hezla Mohamed, Ram Chillar, Ishrat Ali, Sheila Clayton, Dennis Slamon, Jaydutt V Vadgama, Clinical significance of Akt and HER2/neu overexpression in African-American and Latina women with breast cancer Breast Cancer Research. ,vol. 10, pp. 1- 19 ,(2008) , 10.1186/BCR1844
Ursula Vinatzer, Brigitta Dampier, Berthold Streubel, Margit Pacher, Michael J. Seewald, Christian Stratowa, Klaus Kaserer, Martin Schreiber, Expression of HER2 and the Coamplified Genes GRB7 and MLN64 in Human Breast Cancer: Quantitative Real-time Reverse Transcription-PCR as a Diagnostic Alternative to Immunohistochemistry and Fluorescence In situ Hybridization Clinical Cancer Research. ,vol. 11, pp. 8348- 8357 ,(2005) , 10.1158/1078-0432.CCR-05-0841